Performance and comparison of assessment models to predict 30-day mortality in patients with hospital-acquired pneumonia

被引:9
|
作者
Wen, Jia-Ning [1 ]
Li, Nan [2 ]
Guo, Chen-Xia [1 ]
Shen, Ning [1 ]
He, Bei [1 ]
机构
[1] Peking Univ Third Hosp, Dept Resp Med, Beijing 100191, Peoples R China
[2] Peking Univ Third Hosp, Res Ctr Clin Epidemiol, Beijing 100191, Peoples R China
关键词
Hospital-acquired pneumonia; Mortality; Sequential Organ Failure Assessment (SOFA); Acute Physiology and Chronic Health Evaluation II (APACHE II); Quick Sequential Organ Failure Assessment (qSOFA); INTERNATIONAL CONSENSUS DEFINITIONS; VENTILATOR-ASSOCIATED PNEUMONIA; SEPTIC SHOCK; CLINICAL-CRITERIA; APACHE-II; SEVERITY; SEPSIS; MANAGEMENT; SCORES; SOFA;
D O I
10.1097/CM9.0000000000001252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection in China with substantial morbidity and mortality. But no specific risk assessment model has been well validated in patients with HAP. The aim of this study was to investigate the published risk assessment models that could potentially be used to predict 30-day mortality in HAP patients in non-surgical departments. Methods This study was a single-center, retrospective study. In total, 223 patients diagnosed with HAP from 2012 to 2017 were included in this study. Clinical and laboratory data during the initial 24 hours after HAP diagnosis were collected to calculate the pneumonia severity index (PSI); consciousness, urea nitrogen, respiratory rate, blood pressure, and age >= 65 years (CURB-65); Acute Physiology and Chronic Health Evaluation II (APACHE II); Sequential Organ Failure Assessment (SOFA); and Quick Sequential Organ Failure Assessment (qSOFA) scores. The discriminatory power was tested by constructing receiver operating characteristic (ROC) curves, and the areas under the curve (AUCs) were calculated. Results The all-cause 30-day mortality rate was 18.4% (41/223). The PSI, CURB-65, SOFA, APACHE II, and qSOFA scores were significantly higher in non-survivors than in survivors (all P < 0.001). The discriminatory abilities of the APACHE II and SOFA scores were better than those of the CURB-65 and qSOFA scores (ROC AUC: APACHE II vs. CURB-65, 0.863 vs. 0.744, Z = 3.055, P = 0.002; APACHE II vs. qSOFA, 0.863 vs. 0.767, Z = 3.017, P = 0.003; SOFA vs. CURB-65, 0.856 vs. 0.744, Z = 2.589, P = 0.010; SOFA vs. qSOFA, 0.856 vs. 0.767, Z = 2.170, P = 0.030). The cut-off values we defined for the SOFA, APACHE II, and qSOFA scores were 4, 14, and 1. Conclusions These results suggest that the APACHE II and SOFA scores determined during the initial 24 h after HAP diagnosis may be useful for the prediction of 30-day mortality in HAP patients in non-surgical departments. The qSOFA score may be a simple tool that can be used to quickly identify severe infections.
引用
收藏
页码:2947 / 2952
页数:6
相关论文
共 50 条
  • [31] Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study
    Héctor Pinargote-Celorio
    Gemma Miralles
    Miguel Cano
    Esther Caparros
    Joaquín Portilla
    Gregorio González-Alcaide
    José M. Ramos_Rincón
    European Journal of Clinical Microbiology & Infectious Diseases, 2020, 39 : 299 - 307
  • [32] Using Hospital Outcomes to Predict 30-Day Mortality Among Injured Patients Insured by Medicare
    Gorra, Adam S.
    Clark, David E.
    Mullins, Richard J.
    ARCHIVES OF SURGERY, 2011, 146 (02) : 195 - 200
  • [33] Using an Automated Model to Identify Patients at Risk for 30-Day Hospital Readmission and 30-Day Mortality
    Khan, A.
    Hook, M.
    Singh, M.
    Vollbrect, M.
    Malsch, A.
    Malone, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S125 - S125
  • [34] Community-acquired pneumonia in the elderly: Evidence for marked improvement in 30-day mortality
    Ruhnke, G. W.
    Norton, D. M.
    Cutler, D. M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2007, 22 : 46 - 47
  • [35] Mortality and time to extubation in severe hospital-acquired pneumonia
    Connelly, Sarah M.
    Trinh, Jane V.
    Johnson, Melissa D.
    Dodds-Ashley, Elizabeth S.
    Stout, Jason
    Engemann, John J.
    Friedman, Deborah
    Kaye, Donald
    Kaye, Keith S.
    AMERICAN JOURNAL OF INFECTION CONTROL, 2009, 37 (02) : 143 - 149
  • [36] HOSPITAL VOLUME AND 30-DAY READMISSION RATES AMONG PATIENTS WITH PNEUMONIA
    Carlson, K. B.
    Dabbous, F.
    Kabir, C.
    Nitti, K.
    Blair, C.
    Summerfelt, T.
    VALUE IN HEALTH, 2017, 20 (05) : A351 - A351
  • [37] Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
    Kim, Bo-Guen
    Kang, Minwoong
    Lim, Jihyun
    Lee, Jin
    Kang, Danbee
    Kim, Minjung
    Kim, Jinhee
    Park, Hyejeong
    Min, Kyung Hoon
    Cho, Juhee
    Jeon, Kyeongman
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [38] Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-day Readmission
    Caruana, Rich
    Lou, Yin
    Gehrke, Johannes
    Koch, Paul
    Sturm, Marc
    Elhadad, Noemie
    KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, 2015, : 1721 - 1730
  • [39] Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
    Bo-Guen Kim
    Minwoong Kang
    Jihyun Lim
    Jin Lee
    Danbee Kang
    Minjung Kim
    Jinhee Kim
    Hyejeong Park
    Kyung Hoon Min
    Juhee Cho
    Kyeongman Jeon
    BMC Pulmonary Medicine, 22
  • [40] Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
    Kim, Bo-Guen
    Kang, Danbee
    Min, Kyung Hoon
    Cho, Juhee
    Jeon, Kyeongman
    ANTIBIOTICS-BASEL, 2023, 12 (06):